Quartz7d agobearish
Amgen Q2 2026 earnings beat, raises full-year outlook, drops AMG 513The biotech raised its full-year revenue forecast to $38.2 billion–$39.4 billion after second-quarter revenue rose 10% to $10.1 billion
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
330last 24h
2137last 7d
376● bullish (7d)
188● bearish (7d)
204publishers
Investor's Business Daily26d agobearish
Stock Market Today: Dow Slides As Netflix Plunges On Earnings; SpaceX Slides After Canceled Flight (Live Coverage)Stock Market Today: The Dow Jones index dropped Friday as Netflix stock plunged on earnings. SpaceX shares sold off on a canceled test flight.
Simply Wall St.36d agobearish
Amgen (AMGN) Recalls Put Its Valuation Story Back In FocusAmgen (AMGN) has moved into focus after initiating voluntary nationwide recalls of certain Corlanor and Sensipar tablet lots due to foreign substances and CGMP deviations, prompting investors to reassess drug quality and compliance risks. See our latest analysis for Amgen. Against this recall backdrop, Amgen’s recent momentum has stayed intact, with a 30 day share price return of 5.30% and a year to date share price return of 12.35%. The 1 year total shareholder return of 27.66% and 3 year...
Proactive51d agobearish
Nasdaq tipped to rise after long weekend of Iran talks progress, hawkish Fed still loomsUS futures were pointing higher at the start of the week as investors return from the Juneteenth holiday weekend, with technology stocks expected to lead gains despite lingering uncertainty over the Middle East and the prospect of further Federal Reserve tightening. Dow Jones futures were up...
